MariMed Inc.
MRMD
$0.093
-$0.002-2.11%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 39.00M | 40.59M | 40.44M | 37.93M | 38.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.00M | 40.59M | 40.44M | 37.93M | 38.90M |
| Cost of Revenue | 26.29M | 23.81M | 23.53M | 21.46M | 21.58M |
| Gross Profit | 12.71M | 16.78M | 16.91M | 16.47M | 17.32M |
| SG&A Expenses | 13.97M | 15.07M | 15.60M | 14.37M | 14.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.26M | 38.88M | 39.13M | 35.83M | 36.44M |
| Operating Income | -1.26M | 1.71M | 1.31M | 2.11M | 2.46M |
| Income Before Tax | -3.25M | -340.00K | -773.00K | 398.00K | -9.63M |
| Income Tax Expenses | 4.95M | 655.00K | 866.00K | 1.69M | 509.00K |
| Earnings from Continuing Operations | -8.20M | -995.00K | -1.64M | -1.29M | -10.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.00K | -16.00K | -12.00K | -6.00K | -30.00K |
| Net Income | -8.20M | -1.01M | -1.65M | -1.30M | -10.17M |
| EBIT | -1.26M | 1.71M | 1.31M | 2.11M | 2.46M |
| EBITDA | 1.79M | 4.40M | 4.12M | 4.42M | 5.01M |
| EPS Basic | -0.02 | 0.00 | 0.00 | 0.00 | -0.03 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.02 | 0.00 | 0.00 | 0.00 | -0.03 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 381.25M | 380.60M | 379.51M | 375.21M | 376.01M |
| Average Diluted Shares Outstanding | 381.25M | 380.60M | 379.51M | 375.21M | 376.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -11.87% | -- | -- | -- |